CIK 0001527753 · Non-accelerated filer<br>Smaller reporting company
Personalis, Inc.
Sign in to watch- Ticker
- PSNL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275411038
- Phone
- 650-752-1300
- Business address
- 6600 DUMBARTON CIRCLE, FREMONT, CA, 94555
- 4 Returned to the company President and CEO returned 100,000 shares (to the company)
- 4 Open-market sale Chief Financial Officer sold 3,820 shares at $21.92 ($83,734)
- 4 Open-market sale Chief Scientific Officer sold 291 shares at $21.92 ($6,379)
- 4 Grant or award President and CEO acquired 77,272 shares (grant or award)
- 8-K Event Material agreement · New debt or obligation
- 4 Returned to the company President and CEO returned 115,228 shares (to the company)
- 4 Open-market sale Chief Scientific Officer sold 4,436 shares at $21.22 ($94,132)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Grant or award Chief Scientific Officer acquired 10,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 10,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 75,000 shares (grant or award)
- 4 Open-market sale President and CEO sold 110,000 shares at $22.54 ($2,479,400)
- 4 Open-market sale Chief Financial Officer sold 2,421 shares at $22.75 ($55,078)
- 4 Open-market sale Chief Scientific Officer sold 1,101 shares at $22.75 ($25,048)
- 4 Grant or award President and CEO acquired 75,000 shares (grant or award)
- 4 Open-market sale President and CEO sold 110,000 shares at an average $22.43 ($2,467,273)
- 4 Open-market sale Chief Financial Officer sold 2,899 shares at $21.57 ($62,531)
- 4 Open-market sale Chief Scientific Officer sold 291 shares at $21.57 ($6,277)
- 8-K Event Shareholder vote results
Page 20 of 28 · 557 filings